Can evolution-based studies inform modern medicine?

Maicon Landim-Vieira,Jose Renato Pinto

DOI: https://doi.org/10.1126/science.ads2585

IF: 56.9

2024-09-27

Science

Abstract:Comparative genomic analyses provide mechanistic clues to cardiac muscle regulation

multidisciplinary sciences

What problem does this paper attempt to address?

Evolution of translational control and the emergence of genes and open reading frames in human and non-human primate hearts

Jorge Ruiz-Orera,Duncan C Miller,Johannes Greiner,Carolin Genehr,Aliki Grammatikaki,Susanne Blachut,Jeanne Mbebi,Giannino Patone,Anna Myronova,Eleonora Adami,Nikita Dewani,Ning Liang,Oliver Hummel,Michael B Muecke,Thomas B Hildebrandt,Guido Fritsch,Lisa Schrade,Wolfram H Zimmermann,Ivanela Kondova,Sebastian Diecke,Sebastiaan van Heesch,Norbert Hübner

DOI: https://doi.org/10.1038/s44161-024-00544-7

Abstract:Evolutionary innovations can be driven by changes in the rates of RNA translation and the emergence of new genes and small open reading frames (sORFs). In this study, we characterized the transcriptional and translational landscape of the hearts of four primate and two rodent species through integrative ribosome and transcriptomic profiling, including adult left ventricle tissues and induced pluripotent stem cell-derived cardiomyocyte cell cultures. We show here that the translational efficiencies of subunits of the mitochondrial oxidative phosphorylation chain complexes IV and V evolved rapidly across mammalian evolution. Moreover, we discovered hundreds of species-specific and lineage-specific genomic innovations that emerged during primate evolution in the heart, including 551 genes, 504 sORFs and 76 evolutionarily conserved genes displaying human-specific cardiac-enriched expression. Overall, our work describes the evolutionary processes and mechanisms that have shaped cardiac transcription and translation in recent primate evolution and sheds light on how these can contribute to cardiac development and disease.
Present Researching Approaches and Future Prospects forTreatment of Cardiac Diseases - Integrative Medicine

yan feng,hao xu,yixin wang,sup,liping ma,dazhuo shi

DOI: https://doi.org/10.15806/j.issn.2311-8571.2014.0018

2015-01-01

World Journal of Traditional Chinese Medicine

Abstract:The pathogenesis of cardiac diseases is very complex and involved in many gene transcription and protein expression. How to effectively treat the diseases has become the hotspot of modern medicine. Accumulating evidences over the past decades on integrative medicine have shown us hopeful future prospects. With the development of modern biomedicine, such as sketch mapping genomic sequence, functional genomics, proteomics and pharmacogenetics, more advanced techniques could be applied in elucidating the possibly complicated biological networks, or complex pathological and physiological mechanisms underlying cardiac diseases, by which integrative medicine will also bring out some new and more effective strategies in the treatment of cardiac diseases.
Interpretation of murine models of cardiac disease is enhanced by consideration of divergently expressed human-mouse orthologous genes

Oisín Tadhg Cappa,Chris Watson,David Simpson

DOI: https://doi.org/10.1101/2024.06.15.599153

2024-06-17

Abstract:Humans and mice share remarkably similar cardiac anatomy and physiology and have many orthologous genes with high sequence similarity. Together with their small size and short lifespan, these factors are major contributors to the popularity of mice as research models. Nonetheless, findings in mice often fail to translate into humans. We propose that this may be due in part to differences in gene expression. Advances in molecular genomics have enabled profiling of gene expression at the level of individual cells through single-cell RNA-sequencing. Large repositories of human and murine data across many organs and tissues, including the heart, are now available. However, there is currently a lack of comparative research which directly quantifies similarities and differences in expression of orthologous genes between human and mouse. This study is the first, to our knowledge, to directly compare celltype-specific expression conservation and divergence between orthologous genes in human and mouse heart. Cardiac data from 7 human and mouse scRNA-seq publications was retrieved, with mouse data converted to equivalent human gene orthologues. The datasets were integrated and subjected to comparative transcriptomic analysis in R using Seurat. Classical celltype markers did not perform equally across species. We have identified species-conserved celltype marker genes, providing a useful resource to identify cardiac cell populations in both species. Further, we have identified and ranked divergence between species for each cardiac celltype, highlighting genes which vary considerably in expression between human and mouse heart. Many of these have been genetically modified to create mouse models or encode proteins targeted by pharmaceutical drugs. Researchers should carefully consider these highly divergent genes when planning, or interpreting data from, mouse models of human biology.

Genomics
Evolutionary insights into heart regeneration

Jing-Wei Xiong

DOI: https://doi.org/10.1186/s13619-020-00069-x

2020-01-01

Abstract:Some lower vertebrates such as zebrafish and axolotl have incredible cardiac regenerative potential while mammals have very limited ones. Comparative studies among species have revealed that cardiomyocyte polyploidy, endothermy, and injury-induced activation of certain transcriptional factors including AP1 complexes are critical for cardiomyocyte proliferation and heart regeneration during animal evolution. Gaining insights into these evolutionarily conserved mechanisms will likely lead to achieving heart regeneration in non-regenerative mammals including humans.
Recent Progress in Cardiovascular Research Involving Single-Cell Omics Approaches

Zhehao Dai,Seitaro Nomura

DOI: https://doi.org/10.3389/fcvm.2021.783398

2021-12-16

Abstract:Cardiovascular diseases are among the leading causes of morbidity and mortality worldwide. Although the spectrum of the heart from development to disease has long been studied, it remains largely enigmatic. The emergence of single-cell omics technologies has provided a powerful toolbox for defining cell heterogeneity, unraveling previously unknown pathways, and revealing intercellular communications, thereby boosting biomedical research and obtaining numerous novel findings over the last 7 years. Not only cell atlases of normal and developing hearts that provided substantial research resources, but also some important findings regarding cell-type-specific disease gene program, could never have been established without single-cell omics technologies. Herein, we briefly describe the latest technological advances in single-cell omics and summarize the major findings achieved by such approaches, with a focus on development and homeostasis of the heart, myocardial infarction, and heart failure.
Transcriptional control of cardiac energy metabolism in health and disease: Lessons from animal models

Teresa Rubio-Tomás,Carolina Soler-Botija,Ofelia Martínez-Estrada,Josep A Villena

DOI: https://doi.org/10.1016/j.bcp.2024.116185

Abstract:Cardiac ATP production is tightly regulated in order to satisfy the evolving energetic requirements imposed by different cues during health and pathological conditions. In order to sustain high ATP production rates, cardiac cells are endowed with a vast mitochondrial network that is essentially acquired during the perinatal period. Nevertheless, adult cardiac cells also adapt their mitochondrial mass and oxidative function to changes in energy demand and substrate availability by fine-tuning the pathways and mitochondrial machinery involved in energy production. The reliance of cardiac cells on mitochondrial metabolism makes them particularly sensitive to alterations in proper mitochondrial function, so that deficiency in energy production underlies or precipitates the development of heart diseases. Mitochondrial biogenesis is a complex process fundamentally controlled at the transcriptional level by a network of transcription factors and co-regulators, sometimes with partially redundant functions, that ensure adequate energy supply to the working heart. Novel uncovered regulators, such as RIP140, PERM1, MED1 or BRD4 have been recently shown to modulate or facilitate the transcriptional activity of the PGC-1s/ERRs/PPARs regulatory axis, allowing cardiomyocytes to adapt to a variety of physiological or pathological situations requiring different energy provision. In this review, we summarize the current knowledge on the mechanisms that regulate cardiac mitochondrial biogenesis, highlighting the recent discoveries of new transcriptional regulators and describing the experimental models that have provided solid evidence of the relevant contribution of these factors to cardiac function in health and disease.
Revisiting Cardiac Biology in the Era of Single Cell and Spatial Omics

Jack A. Palmer,Nadia Rosenthal,Sarah A. Teichmann,Monika Litvinukova

DOI: https://doi.org/10.1161/circresaha.124.323672

IF: 23.213

2024-06-08

Circulation Research

Abstract:Circulation Research, Volume 134, Issue 12, Page 1681-1702, June 7, 2024. Throughout our lifetime, each beat of the heart requires the coordinated action of multiple cardiac cell types. Understanding cardiac cell biology, its intricate microenvironments, and the mechanisms that govern their function in health and disease are crucial to designing novel therapeutical and behavioral interventions. Recent advances in single-cell and spatial omics technologies have significantly propelled this understanding, offering novel insights into the cellular diversity and function and the complex interactions of cardiac tissue. This review provides a comprehensive overview of the cellular landscape of the heart, bridging the gap between suspension-based and emerging in situ approaches, focusing on the experimental and computational challenges, comparative analyses of mouse and human cardiac systems, and the rising contextualization of cardiac cells within their niches. As we explore the heart at this unprecedented resolution, integrating insights from both mouse and human studies will pave the way for novel diagnostic tools and therapeutic interventions, ultimately improving outcomes for patients with cardiovascular diseases.

cardiac & cardiovascular systems,peripheral vascular disease,hematology
Proteomic Insights into Cardiac Fibrosis: from Pathophysiological Mechanisms to Therapeutic Opportunities

Ruiqiang Qi,E. Lin,Juan Song,Yan Wang,Ling Lin

DOI: https://doi.org/10.3390/molecules27248784

IF: 4.6

2022-01-01

Molecules

Abstract:Cardiac fibrosis is a common pathophysiologic process in nearly all forms of heart disease which refers to excessive deposition of extracellular matrix proteins by cardiac fibroblasts. Activated fibroblasts are the central cellular effectors in cardiac fibrosis, and fibrotic remodelling can cause several cardiac dysfunctions either by reducing the ejection fraction due to a stiffened myocardial matrix, or by impairing electric conductance. Recently, there is a rising focus on the proteomic studies of cardiac fibrosis for pathogenesis elucidation and potential biomarker mining. This paper summarizes the current knowledge of molecular mechanisms underlying cardiac fibrosis, discusses the potential of imaging and circulating biomarkers available to recognize different phenotypes of this lesion, reviews the currently available and potential future therapies that allow individualized management in reversing progressive fibrosis, as well as the recent progress on proteomic studies of cardiac fibrosis. Proteomic approaches using clinical specimens and animal models can provide the ability to track pathological changes and new insights into the mechanisms underlining cardiac fibrosis. Furthermore, spatial and cell-type resolved quantitative proteomic analysis may also serve as a minimally invasive method for diagnosing cardiac fibrosis and allowing for the initiation of prophylactic treatment.
MicroRNAs: novel regulators in cardiac development and disease

Thomas Thum,Daniele Catalucci,Johann Bauersachs

DOI: https://doi.org/10.1093/cvr/cvn137

2008-09-01

Abstract:MicroRNAs (miRNAs) are endogenous, small ribonucleotides regulating the translation of target messenger RNAs that have been shown to be involved in orchestrating growth, development, function, and stress responses of various organs, including the heart. Muscle miRNAs are mainly controlled by a network of myogenic transcription factors, and throughout cardiac development they fine-tune regulatory protein levels in a spatiotemporal manner. Recent profiling studies revealed that miRNA expression patterns are derailed in both human cardiac disease and animal models of cardiac hypertrophy and failure. Modulation of miRNA expression in vitro as well as in vivo has revealed an important role of miRNAs in regulating heart function, particularly cardiac growth and conductance. Here, we overview the recent findings on miRNAs in cardiac development and disease and report the latest advances in the identification and validation of miRNA targets, which are important for a comprehensive understanding of cardiac miRNA function. Finally, we focus on the development and use of miRNA antagonists (antagomirs) to target miRNAs in vivo, which may translate into novel therapeutic strategies for heart disease in the future.
Single-cell multi-modal integrative analyses highlight functional dynamic gene regulatory networks directing human cardiac development

Alyssa R Holman,Shaina Tran,Eugin Destici,Elie N Farah,Ting Li,Aileena C Nelson,Adam J Engler,Neil C Chi

DOI: https://doi.org/10.1016/j.xgen.2024.100680

2024-11-13

Abstract:Illuminating the precise stepwise genetic programs directing cardiac development provides insights into the mechanisms of congenital heart disease and strategies for cardiac regenerative therapies. Here, we integrate in vitro and in vivo human single-cell multi-omic studies with high-throughput functional genomic screening to reveal dynamic, cardiac-specific gene regulatory networks (GRNs) and transcriptional regulators during human cardiomyocyte development. Interrogating developmental trajectories reconstructed from single-cell data unexpectedly reveal divergent cardiomyocyte lineages with distinct gene programs based on developmental signaling pathways. High-throughput functional genomic screens identify key transcription factors from inferred GRNs that are functionally relevant for cardiomyocyte lineages derived from each pathway. Notably, we discover a critical heat shock transcription factor 1 (HSF1)-mediated cardiometabolic GRN controlling cardiac mitochondrial/metabolic function and cell survival, also observed in fetal human cardiomyocytes. Overall, these multi-modal genomic studies enable the systematic discovery and validation of coordinated GRNs and transcriptional regulators controlling the development of distinct human cardiomyocyte populations.
Metabolic landscape in cardiac aging: insights into molecular biology and therapeutic implications

Saiyang Xie,Si-Chi Xu,Wei Deng,Qizhu Tang

DOI: https://doi.org/10.1038/s41392-023-01378-8

IF: 39.3

2023-01-01

Signal Transduction and Targeted Therapy

Abstract:Cardiac aging is evident by a reduction in function which subsequently contributes to heart failure. The metabolic microenvironment has been identified as a hallmark of malignancy, but recent studies have shed light on its role in cardiovascular diseases (CVDs). Various metabolic pathways in cardiomyocytes and noncardiomyocytes determine cellular senescence in the aging heart. Metabolic alteration is a common process throughout cardiac degeneration. Importantly, the involvement of cellular senescence in cardiac injuries, including heart failure and myocardial ischemia and infarction, has been reported. However, metabolic complexity among human aging hearts hinders the development of strategies that targets metabolic susceptibility. Advances over the past decade have linked cellular senescence and function with their metabolic reprogramming pathway in cardiac aging, including autophagy, oxidative stress, epigenetic modifications, chronic inflammation, and myocyte systolic phenotype regulation. In addition, metabolic status is involved in crucial aspects of myocardial biology, from fibrosis to hypertrophy and chronic inflammation. However, further elucidation of the metabolism involvement in cardiac degeneration is still needed. Thus, deciphering the mechanisms underlying how metabolic reprogramming impacts cardiac aging is thought to contribute to the novel interventions to protect or even restore cardiac function in aging hearts. Here, we summarize emerging concepts about metabolic landscapes of cardiac aging, with specific focuses on why metabolic profile alters during cardiac degeneration and how we could utilize the current knowledge to improve the management of cardiac aging.
Cardiomyocyte electrophysiology and its modulation: current views and future prospects

Christopher L-H Huang,Ming Lei

DOI: https://doi.org/10.1098/rstb.2022.0160

2023-06-19

Abstract:Normal and abnormal cardiac rhythms are of key physiological and clinical interest. This introductory article begins from Sylvio Weidmann's key historic 1950s microelectrode measurements of cardiac electrophysiological activity and Singh & Vaughan Williams's classification of cardiotropic targets. It then proceeds to introduce the insights into cardiomyocyte function and its regulation that subsequently emerged and their therapeutic implications. We recapitulate the resulting view that surface membrane electrophysiological events underlying cardiac excitation and its initiation, conduction and recovery constitute the final common path for the cellular mechanisms that impinge upon this normal or abnormal cardiac electrophysiological activity. We then consider progress in the more recently characterized successive regulatory hierarchies involving Ca2+ homeostasis, excitation-contraction coupling and autonomic G-protein signalling and their often reciprocal interactions with the surface membrane events, and their circadian rhythms. Then follow accounts of longer-term upstream modulation processes involving altered channel expression, cardiomyocyte energetics and hypertrophic and fibrotic cardiac remodelling. Consideration of these developments introduces each of the articles in this Phil. Trans. B theme issue. The findings contained in these articles translate naturally into recent classifications of cardiac electrophysiological targets and drug actions, thereby encouraging future iterations of experimental cardiac electrophysiological discovery, and testing directed towards clinical management. This article is part of the theme issue 'The heartbeat: its molecular basis and physiological mechanisms'.
Improved integration of single-cell transcriptome data demonstrates common and unique signatures of heart failure in mice and humans

Mariano Ruz Jurado,Lukas S Tombor,Mani Arsalan,Tomas Holubec,Fabian Emrich,Thomas Walther,Wesley Abplanalp,Ariane Fischer,Andreas M Zeiher,Marcel H Schulz,Stefanie Dimmeler,David John

DOI: https://doi.org/10.1093/gigascience/giae011

IF: 7.658

2024-04-05

GigaScience

Abstract:Cardiovascular research heavily relies on mouse ( Mus musculus ) models to study disease mechanisms and to test novel biomarkers and medications. Yet, applying these results to patients remains a major challenge and often results in noneffective drugs. Therefore, it is an open challenge of translational science to develop models with high similarities and predictive value. This requires a comparison of disease models in mice with diseased tissue derived from humans. To compare the transcriptional signatures at single-cell resolution, we implemented an integration pipeline called OrthoIntegrate , which uniquely assigns orthologs and therewith merges single-cell RNA sequencing (scRNA-seq) RNA of different species. The pipeline has been designed to be as easy to use and is fully integrable in the standard Seurat workflow. We applied OrthoIntegrate on scRNA-seq from cardiac tissue of heart failure patients with reduced ejection fraction (HFrEF) and scRNA-seq from the mice after chronic infarction, which is a commonly used mouse model to mimic HFrEF. We discovered shared and distinct regulatory pathways between human HFrEF patients and the corresponding mouse model. Overall, 54% of genes were commonly regulated, including major changes in cardiomyocyte energy metabolism. However, several regulatory pathways (e.g., angiogenesis) were specifically regulated in humans. The demonstration of unique pathways occurring in humans indicates limitations on the comparability between mice models and human HFrEF and shows that results from the mice model should be validated carefully. OrthoIntegrate is publicly accessible (https://github.com/MarianoRuzJurado/OrthoIntegrate) and can be used to integrate other large datasets to provide a general comparison of models with patient data.

multidisciplinary sciences
Exceptional Evolutionary Divergence of Human Muscle and Brain Metabolomes Parallels Human Cognitive and Physical Uniqueness

Katarzyna Bozek,Yuning Wei,Zheng Yan,Xiling Liu,Jieyi Xiong,Masahiro Sugimoto,Masaru Tomita,Svante Paeaebo,Raik Pieszek,Chet C. Sherwood,Patrick R. Hof,John J. Ely,Dirk Steinhauser,Lothar Willmitzer,Jens Bangsbo,Ola Hansson,Josep Call,Patrick Giavalisco,Philipp Khaitovich

DOI: https://doi.org/10.1371/journal.pbio.1001871

IF: 9.8

2014-01-01

PLoS Biology

Abstract:Metabolite concentrations reflect the physiological states of tissues and cells. However, the role of metabolic changes in species evolution is currently unknown. Here, we present a study of metabolome evolution conducted in three brain regions and two non-neural tissues from humans, chimpanzees, macaque monkeys, and mice based on over 10,000 hydrophilic compounds. While chimpanzee, macaque, and mouse metabolomes diverge following the genetic distances among species, we detect remarkable acceleration of metabolome evolution in human prefrontal cortex and skeletal muscle affecting neural and energy metabolism pathways. These metabolic changes could not be attributed to environmental conditions and were confirmed against the expression of their corresponding enzymes. We further conducted muscle strength tests in humans, chimpanzees, and macaques. The results suggest that, while humans are characterized by superior cognition, their muscular performance might be markedly inferior to that of chimpanzees and macaque monkeys.
Abstract P439: Harnessing Multiscale Models Of A Dilated Cardiomyopathy Mutation For Precision Medicine

Lina Greenberg,W. Tom Stump,Andrea L Bredemeyer,Kory J Lavine,Michael J Greenberg

DOI: https://doi.org/10.1161/res.129.suppl_1.p439

IF: 23.213

2021-09-03

Circulation Research

Abstract:Familial dilated cardiomyopathy (DCM) is a leading cause of both adult and pediatric heart failure. Currently, there is no cure for DCM, and the 5-year transplant free survival rate is <50%. There is therefore an outstanding need to develop new therapeutics. Prior studies have established a strong genetic basis for DCM and identified causative genetic mutations. These observations provide unique opportunities to apply precision medicine approaches that target and circumvent the effects of deleterious mutations. Here, we used a multiscale approach to study the consequences of a human mutation in troponin T that causes DCM, ΔK210. We found that at the molecular scale ΔK210 changes the positioning of tropomyosin along the thin filament, leading to molecular hypocontractility. Using genome edited human stem cell derived cardiomyocytes heterozygous for the mutation, we show reduced cellular contractility at the single cell and tissue levels. Importantly, we demonstrate that mutant tissues show a reduced Frank-Starling response, increased stiffness, and misaligned myocytes. Based on our molecular mechanism, we hypothesized that treatment of ΔK210 with Omecamtiv Mecarbil (OM), a thin filament activator in clinical trials for heart failure, would improve the function of mutant tissues. We found that treatment of ΔK210 molecular complexes and tissues with OM causes a dose-dependent increase in cardiac function, reversing the mutation-induced contractile defect. Taken together, our study demonstrates how mechanistic molecular studies can be harnessed to identify precision medicine therapeutics.

cardiac & cardiovascular systems,peripheral vascular disease,hematology
Non-cardiomyocytes in the heart in embryo development, health, and disease, a single-cell perspective

Shuangyuan Ding,Xingwu Zhang,Hui Qiu,Jiaoyang Wo,Fengzhi Zhang,Jie Na

DOI: https://doi.org/10.3389/fcell.2022.873264

IF: 5.5

2022-01-01

Frontiers in Cell and Developmental Biology

Abstract:Recent single-cell atlases of the heart gave unprecedented details about the diversity of cell types and states during heart development in health and disease conditions. Beyond a profiling tool, researchers also use single-cell analyses to dissect the mechanism of diseases in animal models. The new knowledge from these studies revealed that beating cardiomyocytes account for less than 50% of the total heart cell population. In contrast, non-cardiomyocytes (NCMs), such as cardiac fibroblasts, endothelial cells, and immune cells, make up the remaining proportion and have indispensable roles in structural support, homeostasis maintenance, and injury repair of the heart. In this review, we categorize the composition and characteristics of NCMs from the latest single-cell studies of the heart in various contexts and compare the findings from both human samples and mouse models. This information will enrich our understanding of the cellular basis of heart development and diseases and provide insights into the potential therapeutic targets in NCMs to repair the heart.
Evolution of the fabric of cardiovascular science: Saga of an enduring process of refinement

S K Ghosh,A Priya,R K Narayan

DOI: https://doi.org/10.1016/j.ancard.2021.06.002

Abstract:Background: The core elements of cardiovascular science have been established by scholarly pursuits of numerous scientists across centuries. In this article, we have tried to trace the evolutionary journey of cardiovascular science from a rudimentary form in ancient period to a robust scientific discipline in modern times. Methods: A literature search of relevant, peer-reviewed, published articles was undertaken from indexed databases (Medline & Pubmed, Scopus, Embase, CINAHL Plus, Web of Science and Google Scholar). Results: Cardiovascular science has its roots in antiquity, when Greek scholars mostly relied on philosophical thoughts and ancient texts. This was followed by addition of few structural details to the theory of circulation by Galen based on animal dissection. Arab scholar Ibn al-Nafis provided new insights regarding circulation pathway in humans. Nevertheless, an erroneous concept prevailed into the onset of European Renaissance. Even with legalization of human dissection, little headway could be made till sixteenth century due to persistent reliance of anatomists on ancient Galenic principles. During seventeenth century, the circulatory pathway (as we know it today) was established due to significant contributions from scholars like Harvey and Malpighi. Their efforts were based on findings from experiments and logical conclusions. Eighteenth century witnessed the emergence of autopsy based methods which led to valuable contributions from Vieussens, Thebesius, Morgagni and Hunter regarding normal and pathologic anatomy of cardiovascular system. With structural details mostly established, researchers during nineteenth century focussed on innovations in diagnostic methods based on human experiments. Further development of advanced human experiment models during twentieth century led to emergence of contemporary treatment methods for various cardiac conditions. In the twenty-first century, cardiovascular science is undergoing comprehensive progress at an exponential rate due to technological advances. Conclusion: The evolutionary journey of cardiovascular science as a discipline across centuries has been intriguing and eventful.
Research landscape of genetics in dilated cardiomyopathy: insight from a bibliometric analysis

Tiantian Chao,Yaru Ge,Jinghui Sun,Chenglong Wang

DOI: https://doi.org/10.3389/fcvm.2024.1362551

2024-07-12

Abstract:Background: Dilated cardiomyopathy (DCM) is a heterogeneous myocardial disorder with diverse genetic or acquired origins. Notable advances have been achieved in discovering and understanding the genetics of DCM. This study aimed to depict the distribution of the main research forces, hotspots, and frontiers in the genetics of DCM, thus shaping future research directions. Methods: Based on the documents published in the Web of Science Core Collection database from 2013 to 2022, co-authorship of authors, institutions, and countries/regions, co-citation of references, and co-occurrence of keywords were conducted respectively to present the distribution of the leading research forces, research hotspots, and emerging trends in the genetics of DCM. Results: 4,141 documents were included, and the annual publications have steadily increased. Seidman, Christine E, Meder, Benjamin, Sinagra, Gianfranco were the most productive authors, German Centre for Cardiovascular Research was the most productive institution, and the USA, China, and Germany were the most prolific countries. The co-occurrence of keywords has generated 8 clusters, including DCM, lamin a/c, heart failure, sudden cardiac death, hypertrophic cardiomyopathy, cardiac hypertrophy, arrhythmogenic cardiomyopathy, and next-generation sequencing. Frequent keywords with average publication time after 2019 mainly included arrhythmogenic cardiomyopathy, whole-exome sequencing, RBM 20, phenotype, risk stratification, precision medicine, genotype, and machine learning. Conclusion: The research landscape of genetics in DCM is continuously evolving. Deciphering the genetic profiles by next-generation sequencing and illustrating pathogenic mechanisms of gene variants, establishing innovative treatments for heart failure and improved risk stratification for SCD, uncovering the genetic overlaps between DCM and other inherited cardiomyopathies, as well as identifying genotype-phenotype correlations are the main research hotspots and frontiers in this field.
Immunomodulation for optimal cardiac regeneration: insights from comparative analyses

Luiza Farache Trajano,Nicola Smart

DOI: https://doi.org/10.1038/s41536-021-00118-2

IF: 14.404

2021-02-15

npj Regenerative Medicine

Abstract:Abstract Despite decades of research, regeneration of the infarcted human heart remains an unmet ambition. A significant obstacle facing experimental regenerative therapies is the hostile immune response which arises following a myocardial infarction (MI). Upon cardiac damage, sterile inflammation commences via the release of pro-inflammatory meditators, leading to the migration of neutrophils, eosinophils and monocytes, as well as the activation of local vascular cells and fibroblasts. This response is amplified by components of the adaptive immune system. Moreover, the physical trauma of the infarction and immune-mediated tissue injury provides a supply of autoantigens, perpetuating a cycle of autoreactivity, which further contributes to adverse remodelling. A gradual shift towards an immune-resolving environment follows, culminating in the formation of a collagenous scar, which compromises cardiac function, ultimately driving the development of heart failure. Comparing the human heart with those of animal models that are capable of cardiac regeneration reveals key differences in the innate and adaptive immune responses to MI. By modulating key immune components to better resemble those of regenerative species, a cardiac environment may be established which would, either independently or via the synergistic application of emerging regenerative therapies, improve functional recovery post-MI.

cell & tissue engineering,engineering, biomedical
A short history of the development of mathematical models of cardiac mechanics

Steven A. Niederer,Kenneth S. Campbell,Stuart G. Campbell

DOI: https://doi.org/10.1016/j.yjmcc.2018.11.015

IF: 5.763

2019-02-01

Journal of Molecular and Cellular Cardiology

Abstract:Cardiac mechanics plays a crucial role in atrial and ventricular function, in the regulation of growth and remodelling, in the progression of disease, and the response to treatment. The spatial scale of the critical mechanisms ranges from nm (molecules) to cm (hearts) with the fastest events occurring in milliseconds (molecular events) and the slowest requiring months (growth and remodelling). Due to its complexity and importance, cardiac mechanics has been studied extensively both experimentally and through mathematical models and simulation. Models of cardiac mechanics evolved from seminal studies in skeletal muscle, and developed into cardiac specific, species specific, human specific and finally patient specific calculations. These models provide a formal framework to link multiple experimental assays recorded over nearly 100 years into a single unified representation of cardiac function. This review first provides a summary of the proteins, physiology and anatomy involved in the generation of cardiac pump function. We then describe the evolution of models of cardiac mechanics starting with the early theoretical frameworks describing the link between sarcomeres and muscle contraction, transitioning through myosin-level models to calcium-driven systems, and ending with whole heart patient-specific models.

cardiac & cardiovascular systems,cell biology

Can evolution-based studies inform modern medicine?

Evolution of translational control and the emergence of genes and open reading frames in human and non-human primate hearts

Present Researching Approaches and Future Prospects forTreatment of Cardiac Diseases - Integrative Medicine

Interpretation of murine models of cardiac disease is enhanced by consideration of divergently expressed human-mouse orthologous genes

Evolutionary insights into heart regeneration

Recent Progress in Cardiovascular Research Involving Single-Cell Omics Approaches

Transcriptional control of cardiac energy metabolism in health and disease: Lessons from animal models

Revisiting Cardiac Biology in the Era of Single Cell and Spatial Omics

Proteomic Insights into Cardiac Fibrosis: from Pathophysiological Mechanisms to Therapeutic Opportunities

MicroRNAs: novel regulators in cardiac development and disease

Single-cell multi-modal integrative analyses highlight functional dynamic gene regulatory networks directing human cardiac development

Metabolic landscape in cardiac aging: insights into molecular biology and therapeutic implications

Cardiomyocyte electrophysiology and its modulation: current views and future prospects

Improved integration of single-cell transcriptome data demonstrates common and unique signatures of heart failure in mice and humans

Exceptional Evolutionary Divergence of Human Muscle and Brain Metabolomes Parallels Human Cognitive and Physical Uniqueness

Abstract P439: Harnessing Multiscale Models Of A Dilated Cardiomyopathy Mutation For Precision Medicine

Non-cardiomyocytes in the heart in embryo development, health, and disease, a single-cell perspective

Evolution of the fabric of cardiovascular science: Saga of an enduring process of refinement

Research landscape of genetics in dilated cardiomyopathy: insight from a bibliometric analysis

Immunomodulation for optimal cardiac regeneration: insights from comparative analyses

A short history of the development of mathematical models of cardiac mechanics